🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn if topical netarsudil/latanopro...
Status
Completed
Location
University Hospital Dubrava
Start Date
2025-01-01
Trial ID
NCT06960629
Treatments Being Tested
To evaluate the ocular hypotensive efficacy and ocular and systemic safety ...
Status
Completed
Location
Aerie Pharmaceuticals
Start Date
2014-07
Trial ID
NCT02207491
Treatments Being Tested
The study objective is to determine whether use of Rhopressa improves the a...
Status
Completed
Location
Price Vision Group
Start Date
2019-08-05
Trial ID
NCT04051463
Treatments Being Tested
Evaluation of the ocular hypotensive efficacy and safety of Netarsudil (AR-...
Status
Completed
Location
Aerie Pharmaceuticals
Start Date
2014-07
Trial ID
NCT02207621
In this double-masked, vehicle-controlled, dose-response study, subjects wi...
Status
Completed
Location
Aesthetic Eye Care Institute
Start Date
2012-03
Trial ID
NCT01528787
The goal of this observational study is to evaluate whether prostaglandin a...
Status
Not Yet Recruiting
Location
Department of Ophthalmology University of Bonn
Start Date
2026-05
Trial ID
NCT07074782
The study is intended to test the effectiveness and safety of Netarsudil / ...
Status
Completed
Location
State Hospital - University Medical Center Academical Department of Ophthalmology
Start Date
2017-09-05
Trial ID
NCT03284853
Treatments Being Tested
The purpose of this research study is to compare the effect of Netarsudil a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-12
Trial ID
NCT04064918
Treatments Being Tested
To evaluate effect of Netarsudil Ophthalmic Solution 0.02% on Nocturnal and...
Status
Completed
Location
Nancy Ramirez
Start Date
2016-07
Trial ID
NCT02874846
Treatments Being Tested
To evaluate the ocular hypotensive efficacy of PG324 ophthalmic solution re...
Status
Completed
Location
Kenneth Sall, M.D.
Start Date
2014-01
Trial ID
NCT02057575